Avanos Medical, Inc.

NYSE:AVNS

Medical - Devices

Healthcare
$24.99 +0.22%

+$0.06 today

Market cap
$1.17B
Beta
1.57
P/E (TTM)
-16.7
EPS (TTM)
-$1.50
52W Low $9.30High $25.49

Volume 0.43M

Average 1.49M

AVNS Total Current Liabilities

All obligations due within one year.

Avanos Medical, Inc.NYSE: AVNS

Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total current liabilities falls 4.4% from a year ago

Total current liabilities stood at $131.2M at the end of Q1 FY2026, down 4.4% from a year earlier and down 20.6% from the prior quarter. Over 3 fiscal years it compounded at -4.7% a year.

Context

  • Total current liabilities amounted to 12.5% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
  • Total current liabilities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total current liabilities keeps falling in the next quarterly balance sheet after a -4.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$131.2M-20.6% QoQ
Last fiscal yearDec 2025
$165.2M-0.4% YoY
Year agoMar 2025
$137.2M-4.4% since
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.4%——
1 year-0.4%——
3-year CAGR-4.7%——
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

USD · from the balance sheet

Latest · FY2025
165.2M USD
Year-over-year change
-0.4%
4-year CAGR
+4.4%

Total Current Liabilities vs competitors

How AVNS compares with its peers on the latest reported figures

  • AVNS's Mar 2026 total current liabilities of $131.2M is the 4th highest of the 11 companies compared; the peer median is $57.12M.
  • Its year-over-year change of -4.4% is the 8th highest of 11, against a peer median of +12.0%.
  • Total current liabilities amounts to 12.5% of total assets for AVNS, versus a peer median of 9.6%.
AVNS Competitors Peer median
Total Current Liabilities for AVNS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CYHCommunity Health Systems, Inc.Mar 2026$2.57B +8.3%+0.3%19.5%
VREXVarex Imaging CorporationApr 2026$195.3M +15.7%+2.6%17.9%
BVSBioventus Inc.Mar 2026$148.1M -15.3%-19.2%22.8%
AVNSAvanos Medical, Inc.Mar 2026$131.2M -4.4%-4.7%12.5%
CTKBCytek Biosciences, Inc.Mar 2026$80.94M +19.6%+16.6%18.0%
PACBPacific Biosciences of California, Inc.Mar 2026$65.36M -1.9%-40.9%8.4%
BCYCBicycle Therapeutics plcMar 2026$48.89M -15.2%+2.2%7.5%
FDMT4D Molecular Therapeutics, Inc.Mar 2026$43.4M +61.4%+40.9%8.5%
LABStandard BioTools Inc.Mar 2026$42.2M -25.0%+35.6%6.6%
CBLLCeriBell, Inc.Mar 2026$16.18M +36.8%+24.8%9.1%
CLPTClearPoint Neuro, Inc.Mar 2026$9.48M +38.1%+16.6%10.1%
Peer median (excluding AVNS) $57.12M+12.0%+9.6%9.6%

Competitors are the stored peer set for AVNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents118.5M127.7M87.7M107.7M89.8M
Short-term Investments00000
Net Receivables131.2M167.9M142.8M132.8M103.8M
Inventory159.3M132.3M163.2M138.8M148M
Other Current Assets0196.2M93.3M14.1M13.8M
Total Current Assets427.6M624.1M487M393.4M355.4M
Property, Plant & Equipment (Net)206.7M146.1M144M144.8M141M
Goodwill801.6M760.3M796.1M455.6M394.9M
Intangible Assets141.2M234.2M239.5M112.3M117.8M
Long-term Investments00000
Tax Assets10M4.6M6.5M24.9M33.1M
Other Non-current Assets16.5M17.6M19.3M23.2M31.5M
Total Non-current Assets1.18B1.16B1.21B760.8M718.3M
Total Assets1.6B1.79B1.69B1.15B1.07B
Account Payables56.4M67.9M56.3M54.3M55.5M
Short-term Debt14.7M6.2M8.6M9.4M10.2M
Tax Payables3M21.2M16.7M18M0
Deferred Revenue00000
Other Current Liabilities35.8M7.1M108.7M73.3M0
Total Current Liabilities139.2M191M234.6M165.9M165.2M
Long-term Debt130M226.3M159.4M125.3M90.3M
Deferred Tax Liabilities11.9M25.4M23.8M5.5M6.1M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities9.1M20.5M10M4.4M13.5M
Total Non-current Liabilities193.8M304.7M221.5M159.8M130.3M
Total Liabilities333M495.7M456.1M325.7M295.5M
Common Stock500K500K500K500K500K
Retained Earnings(303.6M)(253.1M)(314.9M)(707M)(779.9M)
Accumulated OCI(33.8M)(35.8M)(27M)(44.6M)(32M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.27B1.29B1.24B828.5M778.2M
Total Debt187.5M277M209.1M170.2M129.1M
Net Debt69M149.3M121.4M62.5M39.3M

Avanos Medical, Inc.

NYSE:AVNS

Intrinsic Alpha fair value

Locked

Current Price

$24.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.